Advertisement
New Zealand markets close in 2 hours 17 minutes
  • NZX 50

    11,874.83
    +71.55 (+0.61%)
     
  • NZD/USD

    0.5947
    +0.0012 (+0.21%)
     
  • NZD/EUR

    0.5549
    +0.0008 (+0.15%)
     
  • ALL ORDS

    7,961.30
    +23.40 (+0.29%)
     
  • ASX 200

    7,707.70
    +24.20 (+0.32%)
     
  • OIL

    83.31
    -0.05 (-0.06%)
     
  • GOLD

    2,331.20
    -10.90 (-0.47%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    17,062.65
    +233.72 (+1.39%)
     
  • NIKKEI 225

    38,332.94
    +780.78 (+2.08%)
     
  • NZD/JPY

    91.9750
    +0.2090 (+0.23%)
     

How Vaccine Cash Could Fuel Pfizer's Future Growth

How Vaccine Cash Could Fuel Pfizer's Future Growth

Thanks to the success of its COVID-19 vaccine, Pfizer (NYSE: PFE) more than doubled its cash hoard in 2021. Here's how the company's big plan might play out. Pfizer set forth an ambitious goal to use its war chest to add $25 billion of revenue by 2030 through mergers and acquisitions, and it's been actively building its pipeline to reach that goal over the last several months.